Evidence map›Paper›PMID 25857297›Full record

Observational studyJournal of nephrology2016

Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy.

Pierre Delanaye, Etienne Cavalier, Coraline Fafin, Bernard E Dubois, Jean-Marie Krzesinski, Olivier Moranne

Abstract readComparative StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of nephrology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.International journal of molecular sciences · 2020
    Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pierre DelanayeDepartment of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium. pierre_delanaye@yahoo.fr.
Etienne CavalierDepartment of Clinical Chemistry, University of Liège, CHU Sart Tilman, Liège, Belgium.
Coraline FafinDivision of Nephrology and Public Health, CHU de Nice, Nice, France.
Bernard E DuboisDepartment of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium.
Jean-Marie KrzesinskiDepartment of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium.
Olivier MoranneDivision of Nephrology and Public Health, CHU de Nice, Nice, France.
University of Liège · BECentre Hospitalier Universitaire de Nice · FRInstitut Universitaire de Recherche Clinique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdherence to therapy is a relevant challenge in chronic hemodialysis patients. The directly observed therapy (DOT) could be an effective method to increase adherence for specific therapies. We aimed to study the performance of DOT versus home medication. We follow the impact of providing native vitamin D directly by the nurse after a dialysis session on the 25-hydroxyvitamin [25(OH)D] concentrations.

methodsIn this observational study, we included 38 dialysis patients treated by stable dosage of cholecalciferol. DOT was implemented in December 2010. We considered the concentrations of 25-OH vitamin D three times before (T1 = June 2010, T2 = July 2010 and T3 = September 2010) and three times after the modification of prescription (T4 = February 2011, T5 = March 2011 and T6 = April 2011).

resultsMedian age was 72 [62; 79] years and 48 % were diabetics. Mean body mass index was 26 ± 5 kg/m(2) and median dialysis vintage was 20 [8; 46] months. The patients were compared to themselves. Before DOT, median concentrations of 25(OH)D were 27 (14-36), 23 (17-31), 31 (22-38) ng/mL at T1, T2 and T3, respectively. When DOT was effective, the concentrations significantly increased to 34 (28-44), 35 (29-41), 39 (32-47) ng/mL at T4, T5 and T6, respectively. Before DOT, 19 patients (50 %) reached the target of 30 ng/mL. After DOT, 29 patients (76 %) reached the target concentration of 30 ng/mL.

conclusionsIn hemodialysis patients, DOT is both simple and effective to increase the therapeutic impact to native vitamin D.

Indexed as

Dietary SupplementsDirectly Observed TherapyRenal DialysisAgedBiomarkersCholecalciferolFemaleHumansMaleMedication AdherenceMiddle AgedRenal Insufficiency, ChronicTime FactorsTreatment OutcomeVitamin DVitamin D Deficiency25-hydroxyvitamin DBiomarkersCholecalciferolVitamin DAdherenceCholecalciferolDirectly observed therapyHemodialysis

Identifiers

PMID25857297
OpenAlexW2084436089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.